Klivenyi Peter
Klivenyi Peter
E-mail megerősítve itt: med.u-szeged.hu
Hivatkozott rá
Hivatkozott rá
Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice
T Barberi, P Klivenyi, NY Calingasan, H Lee, H Kawamata, K Loonam, ...
Nature biotechnology 21 (10), 1200-1207, 2003
Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis
P Klivenyi, RJ Ferrante, RT Matthews, MB Bogdanov, AM Klein, ...
Nature medicine 5 (3), 347-350, 1999
Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease
G Gardian, SE Browne, DK Choi, P Klivenyi, J Gregorio, JK Kubilus, ...
Journal of Biological Chemistry 280 (1), 556-563, 2005
Creatine and cyclocreatine attenuate MPTP neurotoxicity
RT Matthews, RJ Ferrante, P Klivenyi, L Yang, AM Klein, G Mueller, ...
Experimental neurology 157 (1), 142-149, 1999
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers
N Mattsson, U Andreasson, S Persson, H Arai, SD Batish, S Bernardini, ...
Alzheimer's & Dementia 7 (4), 386-395. e6, 2011
Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1, 2, 5, 6-tetrahydropyridine
P Klivenyi, OA Andreassen, RJ Ferrante, A Dedeoglu, G Mueller, ...
Journal of Neuroscience 20 (1), 1-7, 2000
CSF biomarker variability in the Alzheimer's Association quality control program
N Mattsson, U Andreasson, S Persson, MC Carrillo, S Collins, S Chalbot, ...
Alzheimer's & Dementia 9 (3), 251-261, 2013
Mice lacking alpha-synuclein are resistant to mitochondrial toxins
P Klivenyi, D Siwek, G Gardian, L Yang, A Starkov, C Cleren, RJ Ferrante, ...
Neurobiology of disease 21 (3), 541-548, 2006
Nonlinear Decrease over Time in N‐Acetyl Aspartate Levels in the Absence of Neuronal Loss and Increases in Glutamine and Glucose in Transgenic Huntington's …
BG Jenkins, P Klivenyi, E Kustermann, OA Andreassen, RJ Ferrante, ...
Journal of neurochemistry 74 (5), 2108-2119, 2000
Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis
P Klivenyi, M Kiaei, G Gardian, NY Calingasan, MF Beal
Journal of neurochemistry 88 (3), 576-582, 2004
Manganese superoxide dismutase overexpression attenuates MPTP toxicity
P Klivenyi, DS Clair, M Wermer, HC Yen, T Oberley, L Yang, MF Beal
Neurobiology of disease 5 (4), 253-258, 1998
Mice Deficient in Group IV Cytosolic Phospholipase A2 Are Resistant to MPTP Neurotoxicity
P Klivenyi, MF Beal, RJ Ferrante, OA Andreassen, M Wermer, MR Chin, ...
Journal of neurochemistry 71 (6), 2634-2637, 1998
N-acetyl-L-cysteine improves survival and preserves motor performance in an animal model of familial amyotrophic lateral sclerosis
OA Andreassen, A Dedeoglu, P Klivenyi, MF Beal, AI Bush
Neuroreport 11 (11), 2491-2493, 2000
Mice with a partial deficiency of manganese superoxide dismutase show increased vulnerability to the mitochondrial toxins malonate, 3-nitropropionic acid, and MPTP
OA Andreassen, RJ Ferrante, A Dedeoglu, DW Albers, P Klivenyi, ...
Experimental neurology 167 (1), 189-195, 2001
The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection
E Vamos, A Pardutz, P Klivenyi, J Toldi, L Vecsei
Journal of the neurological sciences 283 (1-2), 21-27, 2009
Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial
SE Kasner, B Swaminathan, P Lavados, M Sharma, K Muir, R Veltkamp, ...
The Lancet Neurology 17 (12), 1053-1060, 2018
Mice deficient in dihydrolipoamide dehydrogenase show increased vulnerability to MPTP, malonate and 3‐nitropropionic acid neurotoxicity
P Klivenyi, AA Starkov, NY Calingasan, G Gardian, SE Browne, L Yang, ...
Journal of neurochemistry 88 (6), 1352-1360, 2004
Neuroprotective effects of phenylbutyrate against MPTP neurotoxicity
G Gardian, L Yang, C Cleren, NY Calingasan, P Klivenyi, MF Beal
Neuromolecular medicine 5 (3), 235-241, 2004
Increased vulnerability to 3‐nitropropionic acid in an animal model of Huntington's disease
MB Bogdanov, RJ Ferrante, S Kuemmerle, P Klivenyi, MF Beal
Journal of neurochemistry 71 (6), 2642-2644, 1998
Neuroprotective effects of a novel kynurenic acid analogue in a transgenic mouse model of Huntington’s disease
D Zádori, G Nyiri, A Szőnyi, I Szatmári, F Fülöp, J Toldi, TF Freund, ...
Journal of neural transmission 118 (6), 865-875, 2011
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20